Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
3.4750
-0.0250
(-0.71%)
As of 1:25:22 PM EST. Market Open.
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 6 | 3 | 6 | 5 |
Avg. Estimate | -0.1 | -0.15 | -0.58 | -0.44 |
Low Estimate | -0.11 | -0.18 | -0.59 | -0.63 |
High Estimate | -0.08 | -0.12 | -0.56 | -0.28 |
Year Ago EPS | -0.14 | -0.19 | -0.51 | -0.58 |
Revenue Estimate
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 8 | 3 | 8 | 7 |
Avg. Estimate | 10.13M | 6.53M | 25.75M | 45.98M |
Low Estimate | 5.78M | 3.44M | 21.37M | 26.8M |
High Estimate | 12.64M | 10M | 28.22M | 69M |
Year Ago Sales | 4.82M | 3.8M | 34.16M | 25.75M |
Sales Growth (year/est) | 110.07% | 71.91% | -24.64% | 78.60% |
Earnings History
Currency in USD | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
---|---|---|---|---|
EPS Est. | -0.15 | -0.16 | -0.17 | -0.14 |
EPS Actual | -0.14 | -0.19 | -0.13 | -0.16 |
Difference | 0.01 | -0.03 | 0.04 | -0.02 |
Surprise % | 8.41% | -16.33% | 25.00% | -17.07% |
EPS Trend
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | -0.1 | -0.15 | -0.58 | -0.44 |
7 Days Ago | -0.1 | -0.15 | -0.58 | -0.44 |
30 Days Ago | -0.1 | -0.15 | -0.58 | -0.44 |
60 Days Ago | -0.09 | -0.15 | -0.58 | -0.43 |
90 Days Ago | -0.1 | -0.14 | -0.57 | -0.43 |
EPS Revisions
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | 2 | -- | 1 | 1 |
Up Last 30 Days | 2 | -- | 1 | 1 |
Down Last 7 Days | 1 | 1 | -- | 2 |
Down Last 30 Days | 1 | 1 | 1 | 2 |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
OABI | 30.95% | 21.05% | -13.40% | 24.61% |
S&P 500 | 16.00% | 7.22% | 10.60% | 14.10% |
Upgrades & Downgrades
Reiterates | Benchmark: Buy to Buy | 11/14/2024 |
Reiterates | HC Wainwright & Co.: Buy to Buy | 11/14/2024 |
Reiterates | Benchmark: Buy to Buy | 8/19/2024 |
Reiterates | RBC Capital: Outperform to Outperform | 8/16/2024 |
Reiterates | HC Wainwright & Co.: Buy to Buy | 8/12/2024 |
Reiterates | Benchmark: Buy to Buy | 5/14/2024 |
Related Tickers
LGND Ligand Pharmaceuticals Incorporated
119.53
+3.34%
ARMP Armata Pharmaceuticals, Inc.
2.0576
-1.08%
GNFT Genfit S.A.
3.5400
0.00%
XOMA XOMA Royalty Corporation
22.31
-1.72%
PVLA Palvella Therapeutics, Inc.
18.90
+0.27%
NBTX Nanobiotix S.A.
3.5100
-4.10%
ARTV Artiva Biotherapeutics, Inc.
3.9400
+5.63%
KRON Kronos Bio, Inc.
0.9550
-1.05%
IVA Inventiva S.A.
3.1650
-2.91%
MEIP MEI Pharma, Inc.
2.5900
-1.15%